Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
174 hedge funds and large institutions have $381M invested in Avid Bioservices, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 39 closing their positions.
166% more call options, than puts
Call options by funds: $218K | Put options by funds: $82K
16% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 50
13% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 39
2% more funds holding
Funds holding: 170 → 174 (+4)
36% less capital invested
Capital invested by funds: $591M → $381M (-$210M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$26.9M |
| 2 |
Morgan Stanley
New York
|
+$7.16M |
| 3 |
State Street
Boston,
Massachusetts
|
+$6.76M |
| 4 |
Two Sigma Investments
New York
|
+$3.46M |
| 5 |
2C
272 Capital
Dallas,
Texas
|
+$3.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$28.3M |
| 2 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$21.3M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$15.8M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$14.7M |
| 5 |
Jennison Associates
New York
|
-$14M |
CDMO Hedge Fund Activity: Q4 2023 in Review
174 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2023, worth a combined $381M — down 36% from $591M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new CDMO positions and 39 closed out — a net gain of 5 holders — while 58 added to existing stakes and 50 trimmed.
The largest buyer was Millennium Management, adding an estimated $26.9M. The largest seller was BlackRock, cutting an estimated $28.3M.
- 174 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2023, up from 170 in Q3 2023.
- Funds reported $381M of Avid Bioservices, Inc. Common Stock stock for Q4 2023, down 36% quarter-over-quarter.
- 44 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2023 and 39 closed out, a net change of +5 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2023 was Millennium Management, an estimated $26.9M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2023 was BlackRock, an estimated $28.3M sold.
Based on aggregated 13F filings for Q4 2023.